Matrix metalloproteinase inhibitors for treatment of cancer

被引：27

作者：

Skiles, JW ^{[1
]}

Monovich, LG ^{[1
]}

Jeng, AY ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, Summit, NJ 07901 USA

来源：

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35 | 2000年 / 35卷

关键词：

D O I：

10.1016/S0065-7743(00)35016-3

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：167 / 176

页数：10

共 71 条

[61]

Shalinsky DR, 1999, CLIN CANCER RES, V5, P1905

[62]

Sugita K, 1999, IDrugs, V2, P327

[63] Identification of highly selective inhibitors of collagenase-1 from combinatorial libraries of diketopiperazines [J].

Szardenings, AK ;

Antonenko, V ;

Campbell, DA ;

DeFrancisco, N ;

Ida, S ;

Shi, LH ;

Sharkov, N ;

Tien, D ;

Wang, YW ;

Navre, M .

JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (08) :1348-1357

[64] Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members [J].

Velasco, G ;

Pendás, AM ;

Fueyo, A ;

Knäuper, V ;

Murphy, G ;

López-Otín, C .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (08) :4570-4576

[65]

VENKATESAN AM, 1999, Patent No. 42436

[66]

White AD, 1997, CURR PHARM DESIGN, V3, P45

[67] Design and therapeutic application of matrix metalloproteinase inhibitors [J].

Whittaker, M ;

Floyd, CD ;

Brown, P ;

Gearing, AJH .

CHEMICAL REVIEWS, 1999, 99 (09) :2735-2776

[68] MATRIX METALLOPROTEINASES AND THEIR INHIBITORS IN CONNECTIVE-TISSUE REMODELING [J].

WOESSNER, JF .

FASEB JOURNAL, 1991, 5 (08) :2145-2154

[69]

ZASK A, 1998, CURR PHARM DESIGN, V2, P624

[70]

Zhang H T, 1998, Expert Opin Investig Drugs, V7, P1629, DOI 10.1517/13543784.7.10.1629

← 1 2 3 4 5 6 7 8 →